Source document or public record

FDA 510(k) K223187 — HemosIL Liquid Anti-Xa

FDA 510(k) index record K223187. Device: HemosIL Liquid Anti-Xa. Applicant as listed: Instrumentation Laboratory CO. Decision date: 2023-06-23.

OtherU.S. Food and Drug Administration (FDA)2023-06-23

Source

"device_name": "HemosIL Liquid Anti-Xa"

This entry describes what the document covers; the document itself is the authority. Listing it is not agreement with its conclusions.

Review and references

Reviewer

Automated FDA record verification

Published

2026-10-20

Updated

2026-10-20

Disclaimer

professional use

FDA 510(k) public index record K223187.

Device name: HemosIL Liquid Anti-Xa. Applicant as listed: Instrumentation Laboratory CO.

Decision date: 2023-06-23. Decision wording: Substantially Equivalent.

Product code: QLU. Regulation: 21 CFR 864.7295. Medical specialty: Hematology.

This page reproduces regulator index metadata. The applicant field identifies the submitter and is not a manufacturer identity check. Consult the original FDA record for the decision and associated documents; this index does not verify current commercial availability or clinical performance.

Interested in these solutions?

Submit a sourcing request with the assays, volumes, and timeline of your own project.